Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

262
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
262
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

393
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
393
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

3.3K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.3K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

3.0K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.0K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

694
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
694
Insulin Formulations: Types and Delivery01:27

Insulin Formulations: Types and Delivery

273
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
273

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predicting Risk for Diabetic Ketoacidosis in Children Recently Diagnosed with Type 1 Diabetes Using the Risk Index for Diabetic Ketoacidosis.

Diabetes technology & therapeutics·2026
Same author

Bringing early detection to life: real-world operationalization of a presymptomatic type 1 diabetes screening and monitoring pilot program.

BMJ open diabetes research & care·2026
Same author

DiaBetter Together: Outcomes of a Randomized Controlled Trial Evaluating a Peer Mentor Behavioral Intervention for Young Adults With Type 1 Diabetes During the Transfer From Pediatric to Adult Care.

Diabetes care·2026
Same author

Safety and Glycemic Outcomes Among Youth With New-Onset Type 1 Diabetes Using a Tubeless Automated Insulin Delivery System.

Journal of diabetes research·2026
Same author

It Is Time to Act: Making Diabetes Distress Screening Standard in Clinical Practice.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·2026
Same author

Lean on me: Social factors and diabetes outcomes among young adults with type 1 diabetes prior to transitioning to adult care.

Diabetic medicine : a journal of the British Diabetic Association·2026
Same journal

Effectiveness of Vitamin B1-6-12 Supplementation Compared With Vitamin B12 and Gabapentin in Patients With Diabetic Peripheral Neuropathy.

Clinical diabetes : a publication of the American Diabetes Association·2025
Same journal

In Appreciation of Our Journal and Its Extended Family.

Clinical diabetes : a publication of the American Diabetes Association·2025
Same journal

A Systematic Review of Factors Associated With Transition Readiness and the Transfer to Adult Health Care for Young People With Diabetes.

Clinical diabetes : a publication of the American Diabetes Association·2025
Same journal

Blueprint for Comprehensive Diabetes Care in Student-Run Free Clinics: A Model for Accessible Health Care.

Clinical diabetes : a publication of the American Diabetes Association·2025
Same journal

Reducing Diabetic Ketoacidosis Incidence in Children With Type 1 Diabetes Through Wraparound Services at Texas Children's Hospital: The REACH Program.

Clinical diabetes : a publication of the American Diabetes Association·2025
Same journal

Tirzepatide-Induced Weight Loss and Normalization of Glycemia With Nerve Regeneration in Type 2 Diabetes: A Case Report.

Clinical diabetes : a publication of the American Diabetes Association·2025
See all related articles

Related Experiment Video

Updated: Sep 13, 2025

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.0K

ROCKET T1D Remote Patient Monitoring Program: Launching Diabetes Management Habits in New-Onset Diabetes.

Guido Alarcon1, Sarah K Lyons1, Don Buckingham2

  • 1Department of Pediatrics, Division of Diabetes and Endocrinology, Baylor College of Medicine, Texas Children's Hospital, Houston, TX.

Clinical Diabetes : a Publication of the American Diabetes Association
|July 31, 2025
PubMed
Summary
This summary is machine-generated.

The ROCKET T1D program successfully empowered youth with new-onset type 1 diabetes. Participants improved diabetes management habits and achieved better glycemic control using technology.

More Related Videos

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
04:24

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

11.7K
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.5K

Related Experiment Videos

Last Updated: Sep 13, 2025

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.0K
A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
04:24

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

11.7K
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.5K

Area of Science:

  • Pediatric Endocrinology
  • Digital Health
  • Diabetes Technology

Background:

  • Type 1 Diabetes (T1D) presents unique management challenges for youth.
  • Effective self-management is crucial for long-term health outcomes in pediatric T1D.
  • Emerging technologies offer new avenues for diabetes care and monitoring.

Purpose of the Study:

  • To evaluate the ROCKET T1D remote patient monitoring program.
  • To assess the program's impact on diabetes self-management habits in youth with new-onset T1D.
  • To determine if the program improves glycemic outcomes through technology adoption.

Main Methods:

  • The ROCKET T1D program utilized remote patient monitoring.
  • Participants engaged with emerging diabetes technology and received outreach.
  • Data was collected over a 3-month 'Launch' phase.

Main Results:

  • Youth demonstrated improved diabetes self-management behaviors.
  • Key improvements included premeal bolusing and diabetes device utilization.
  • Participants showed enhanced data review and dose adjustment skills.
  • Positive trends in glycemic outcomes were observed during the program.

Conclusions:

  • Remote patient monitoring, like ROCKET T1D, can empower youth with T1D.
  • Technology integration supports improved self-care habits and glycemic control.
  • The program shows promise for enhancing diabetes management in adolescents.